|
|
 |
|
Viewing report
|
|
|
|
Glaucoma Pharmaceuticals - Global Strategic Business Report
Global Industry Analysts, Inc., Feb 2010, Pages: 260
This report analyzes the Global market for Glaucoma Pharmaceuticals in US$ Million.
The report provides separate comprehensive analytics for US, and Rest of World.
Annual forecasts are provided for the period 2006 through 2015.
The report profiles 32 companies including many key and niche players worldwide such as:
- Acadia Pharmaceuticals, Inc.
- Alcon Laboratories, Inc.
- Allergan, Inc.
- Falcon Pharmaceuticals, Ltd.
- Inotek Pharmaceuticals Corporation
- Inspire Pharmaceuticals, Inc.
- Lexicon Pharmaceuticals, Inc.
- Merck & Co., Inc.
- NicOx S.A
- Novartis International AG
- Pfizer, Inc.
- Santen Pharmaceutical Co., Ltd.
Market data and analytics are derived from primary and secondary research.
Company profiles are mostly extracted from URL research and reported select online sources.
Please note: Reports are sold as single-site single-user licenses. The delivery time for hard copies is between 3-5 business days, as each hard copy is custom printed for the organization ordering it. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks.
For information on site licence pricing please click on Enquire before buying
Customers who bought this item also bought
Opthalmic Pharmaceutical Drugs - Global Strategic Business Report
Ophthalmology Drug Futures: Sight Preservation in Chronic Eye Diseases
Anti-Hypertensive Drugs - Global Strategic Business Report
Glaucoma Therapeutics - Pipeline Assessment and Market Forecasts to 2018
Orphan Disease Series - Glaucoma: Can Orphan-Drug Status Offer an Entry into a Mature Market?
U.S. Glaucoma Pharmaceuticals Market
Analysis of the United States Glaucoma Pharmaceuticals Market
Ocular Hypertension - Pipeline Review, H2 2011
Anti-Infectives - Global Strategic Business Report
Ocular Hypertension - Pipeline Review, H1 2012
|
|
|
|
